Humalog KwikPen 200
Save up to 77%
Available Options
200IU/ml
5 pens (3ml each)
Important Information
- • A valid prescription is required for all orders
- • Orders are shipped within 3–7 business days
- • Express shipping with cold chain packaging to keep your medication safe and effective
Description
Humalog KwikPen 200 is a pre-filled insulin pen delivering insulin lispro, a rapid-acting human insulin analog formulated at double concentration (U-200). It is designed for adults with diabetes who require large daily doses of mealtime insulin and prefer a lower injection volume.
With 200 units of insulin per mL, Humalog KwikPen 200 allows patients to inject half the volume compared to standard U-100 insulin pens while achieving the same glucose-lowering effect. It begins working approximately 15 minutes after injection and is typically used in combination with a long-acting basal insulin.
This concentrated formulation is not intended for intravenous use or for insulin pump therapy, and it should be prescribed only to patients who are familiar with insulin management.
Fact Table
| Formula | C257H383N65O77S6 |
|---|---|
| License | EU EMA, US FDA |
| Chemical Name | Insulin lispro |
| Dosage (Strength) |
|
| Route | Subcutaneous injection |
| Bioavailability | ~55–60% |
Directions
- Inject Humalog KwikPen 200 within 15 minutes before a meal or immediately afterward. Use subcutaneously in the abdomen, upper arm, or thigh.
- Rotate sites regularly to avoid skin thickening.
- Use only under the guidance of a healthcare provider familiar with concentrated insulin use.
Ingredients
Each mL of Humalog U-200 contains 200 units of insulin lispro and inactive ingredients such as glycerin, zinc oxide, and metacresol for stability.
Cautions
- Do not use during hypoglycemia or if allergic to insulin lispro.
- Use with caution in patients with renal or hepatic impairment. Monitor glucose levels regularly.
- Store unopened pens in a refrigerator (36–46°F / 2–8°C).
- After first use, keep pens at room temperature (below 86°F / 30°C) and use within 28 days. Do not freeze.
Interactions
Inform your doctor of all medications you are taking, including beta-blockers, diuretics, and corticosteroids, as they may alter insulin needs.
Side Effects
- Common: hypoglycemia, injection site discomfort, and weight gain.
- Rare but serious: severe hypoglycemia, allergic reactions, or hypokalemia. Seek emergency care for signs of insulin overdose or allergic reaction.
Frequently Asked Questions
What is Humalog KwikPen 200 used for?
It’s used to control blood sugar spikes at mealtime in adults who need larger doses of rapid-acting insulin.
How is U-200 different from U-100 Humalog?
Humalog U-200 has twice the insulin concentration, allowing for lower injection volumes for the same insulin dose.
When should I inject Humalog KwikPen 200?
Inject within 15 minutes before or immediately after eating, as directed by your doctor.
Can children use Humalog KwikPen 200?
No, it is not approved for pediatric use. It is indicated only for adults.
Is the dose the same as Humalog U-100?
Yes, dosing is the same unit-for-unit. The difference is in the concentration and volume of injection.
Can I use Humalog U-200 in an insulin pump?
No. It is not approved for use in insulin pumps or for intravenous administration.
Does Humalog cause weight gain?
Weight gain can occur, particularly if caloric intake is increased or hypoglycemia is frequent.
What are the storage guidelines for U-200 KwikPen?
Refrigerate before opening. After first use, store at room temperature and use within 28 days.
Is Humalog KwikPen 200 approved internationally?
Currently, it is FDA-approved for use in the United States.
What are the side effects of Humalog?
Side effects include low blood sugar, allergic reactions, and injection site issues.
Important Note
The information above is provided for educational purposes only and should not replace professional medical advice. Please consult a qualified healthcare provider for personalized guidance on medication safety, suitability, and proper use.